Adtalem Global Education Inc. (NYSE:CVSA – Get Free Report) CFO Robert Phelan sold 2,900 shares of the company’s stock in a transaction on Tuesday, July 7th. The stock was sold at an average price of $135.41, for a total value of $392,689.00. Following the completion of the sale, the chief financial officer directly owned 52,906 shares in the company, valued at approximately $7,164,001.46. The trade was a 5.20% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Adtalem Global Education Trading Up 0.2%
Adtalem Global Education stock traded up $0.32 on Thursday, hitting $131.17. 316,206 shares of the stock traded hands, compared to its average volume of 371,981. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.70 and a current ratio of 0.70. The stock has a market capitalization of $4.46 billion, a price-to-earnings ratio of 20.43, a P/E/G ratio of 1.02 and a beta of 0.62. The firm has a fifty day moving average of $124.04. Adtalem Global Education Inc. has a 1 year low of $86.97 and a 1 year high of $156.26.
Adtalem Global Education (NYSE:CVSA – Get Free Report) last released its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping analysts’ consensus estimates of $1.73 by $0.25. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. The firm had revenue of $487.03 million for the quarter. During the same period in the prior year, the company earned $1.92 earnings per share. The firm’s quarterly revenue was up 4.5% compared to the same quarter last year. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. As a group, analysts predict that Adtalem Global Education Inc. will post 8.04 earnings per share for the current year.
Wall Street Analysts Forecast Growth
View Our Latest Stock Report on CVSA
Adtalem Global Education Company Profile
Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.
Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.
Featured Articles
- Five stocks we like better than Adtalem Global Education
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Receive News & Ratings for Adtalem Global Education Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adtalem Global Education and related companies with MarketBeat.com's FREE daily email newsletter.
